Health
Merck KGaA Lifts Outlook on Strong Sales of Drugs, Electronics
The Merck KGaA headquarters in Darmstadt, Germany.
Photographer: Martin Leissl/BloombergThis article is for subscribers only.
Merck KGaA raised its earnings forecast for the year amid strong demand for its pharmaceutical and electronics businesses, showing its post-Covid pivot is picking up steam.
The German company now expects adjusted earnings of €8.20 ($8.91) to €9.30 per share this year, up from a previous range of €8.05 to €9.10, according to a statement late Friday.